Octopus Biosafety (STU:OCR) EBIT: €-0.84 Mil (TTM As of Dec. 2024)


STU:OCR Octopus Biosafety STU:OCR
11 GF Score
Price €0.10
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety EBIT?

Octopus Biosafety STU:OCR 11 EBIT is €-0.84 Mil as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 11/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review.

Octopus Biosafety's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was €-0.84 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.84 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Octopus Biosafety's annualized ROC % for the quarter that ended in Dec. 2024 was -80.62%. Octopus Biosafety's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -804.81%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Octopus Biosafety's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -3.94%.

Octopus Biosafety  (STU:OCR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Octopus Biosafety's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-0.539 * ( 1 - 24.91% )/( (0.248 + 0.756)/ 2 )
=-0.4047351/0.502
=-80.62 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.771 - 0.409 - ( 0.126 - max(0, 0.433 - 0.547+0.126))
=0.248

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.489 - 0.408 - ( 0.023 - max(0, 0.985 - 0.31+0.023))
=0.756

Note: The Operating Income data used here is one times the annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Octopus Biosafety's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.837/( ( (0.126 + max(-0.286, 0)) + (0.082 + max(-0.553, 0)) )/ 2 )
=-0.837/( ( 0.126 + 0.082 )/ 2 )
=-0.837/0.104
=-804.81 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.062 + 0.04 + 0.027) - (0.409 + 0 + 0.006)
=-0.286

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.025 + 0 + 0.02) - (0.408 + 0 + 0.19)
=-0.553

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Octopus Biosafety's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=-0.837/21.246
=-3.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety EBIT Related Terms

Octopus Biosafety EBIT Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety EBIT Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.40 -1.12 -0.73 -1.44 -0.84

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.40 -1.12 -0.73 -1.44 -0.84

STU:OCR vs DELL, SNDK, ANET: EBIT Comparison

For the Computer Hardware subindustry, Octopus Biosafety's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Octopus Biosafety EV-to-EBIT vs Hardware Industry

For the Hardware industry and Technology sector, Octopus Biosafety's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Octopus Biosafety's EV-to-EBIT falls into.


STU:OCR
11GF Score
Octopus Biosafety STU:OCR
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-0.84 Mil mean?
Octopus Biosafety (STU:OCR) has a EBIT of €-0.84 Mil as of Dec. 2024. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Octopus Biosafety.
Is Octopus Biosafety's EBIT too high?
Octopus Biosafety's current EBIT is €-0.84 Mil. Overall, Octopus Biosafety has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's EBIT compare to DELL and SNDK?
Octopus Biosafety's EBIT of €-0.84 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Hardware company?
A good EBIT depends on the Hardware industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Octopus Biosafety. Octopus Biosafety's current EBIT is €-0.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current EBIT of €-0.84 Mil. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current EBIT is €-0.84 Mil. Octopus Biosafety's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current EBIT is €-0.84 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.

Key valuation signals for STU:OCR:

  • EBIT: €-0.84 Mil
  • GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
  • GF Score™: 11/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
11GF Score

Get the complete analysis for STU:OCR

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.05
GF Value